UK-based life-science company which specializes in genetic innovation
Biocentis has raised €16M across 1 funding round from 3 investors, most recently a round in Nov 2025. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-11-19 | Other | €16M |
| Algebris Investments,Grantham Foundation for the Protection of the Environment (US),Wellcome |
| View deal → |
